+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Diagnostic & Treatment Market - Global Forecast 2026-2032- Product Image
Allergy Diagnostic & Treatment Market - Global Forecast 2026-2032- Product Image
Sale

Allergy Diagnostic & Treatment Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134480
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Allergy Diagnostic & Treatment Market is projected to reach USD 4.95 Billion in 2026. It is expected to continue growing at a CAGR of 7.04%, reaching USD 7.44 Billion by 2032.

Allergy Diagnostics and Treatment: Executive Overview

Allergy diagnostics and treatment encompass testing, clinical assessment, pharmacological management, immunotherapy, avoidance strategies, and digital or connected tools that support long-term disease control. Demand is shaped by the growing need to distinguish allergic disease from other respiratory, dermatological, gastrointestinal, and systemic conditions. Clinical practice is increasingly focused on earlier identification, patient-specific care pathways, treatment adherence, and coordinated management of multimorbidity.

How Allergy Care Is Being Reshaped by Precision and Access

The landscape is shifting from symptom relief alone toward integrated diagnosis and disease management. Component-resolved diagnostics, molecular allergen characterization, improved skin and blood testing workflows, and standardized clinical protocols are helping clinicians refine sensitization profiles and interpret results in context. At the same time, care delivery is being influenced by telemedicine, decentralized testing, pharmacy-based services, biologic therapies, sublingual and subcutaneous immunotherapy, and stronger emphasis on safety, adherence, and patient education. Persistent challenges include unequal access to specialists, differences in reimbursement, test interpretation, supply continuity, and the need to avoid unnecessary elimination diets or treatments based solely on sensitization findings.

Artificial Intelligence Is Supporting Interpretation, Triage, and Personalized Care

Artificial intelligence is being applied to allergy care through clinical decision support, symptom-tracking tools, image-assisted assessment of dermatological manifestations, automated review of laboratory data, and risk stratification for follow-up. These applications may help identify patterns across environmental exposure, medication history, symptoms, and treatment response, while supporting more consistent triage and documentation. However, clinical value depends on representative training data, transparent validation, interoperability with health records, privacy safeguards, and physician oversight. AI should complement-rather than replace-history taking, physical examination, validated testing, and shared clinical decision-making.

Regional Insights: Uneven Access Meets Broadening Clinical Need

North America is characterized by advanced specialist services, broad availability of diagnostic modalities, and growing interest in biologics, immunotherapy, and digital monitoring, while affordability and care fragmentation remain important considerations. Latin America is seeing stronger attention to standardized diagnosis and outpatient management, but access varies with healthcare infrastructure, specialist density, and reimbursement. Europe benefits from established allergy networks, guideline-driven practice, and cross-border research collaboration, alongside regulatory and health-system differences. The Middle East is investing in modern clinical capacity, with demand influenced by urbanization, environmental exposures, and variable specialist access. Africa faces substantial gaps in diagnostics, trained personnel, and treatment continuity, making primary-care integration and scalable education particularly important. Asia-Pacific combines sophisticated markets with significant unmet need; urban pollution, changing lifestyles, and wide differences in healthcare access are encouraging greater focus on screening, precision diagnostics, and affordable long-term management.

Group Insights: Policy, Trade, and Health-System Priorities Shape Adoption

ASEAN countries show diverse levels of diagnostic capacity and reimbursement, creating a strong case for regionally adaptable protocols, workforce development, and affordable testing pathways. BRICS members combine large and varied patient populations with differing regulatory systems, public-health priorities, and domestic manufacturing capabilities; collaboration on access and clinical standards can reduce fragmentation. The European Union emphasizes evidence-based care, patient safety, data governance, and coordinated regulation, while national reimbursement decisions continue to influence implementation. G7 countries generally provide strong research ecosystems and specialist capabilities, but also face pressure to control treatment costs and improve equitable access. GCC health systems are expanding advanced care and digital infrastructure, with opportunities to strengthen allergy services through coordinated referral networks and prevention programs. NATO members span diverse healthcare systems, making interoperability, preparedness, and continuity of essential medicines relevant to allergy management.

Country Insights: Local Systems Determine Diagnostic and Treatment Pathways

Australia combines strong clinical expertise with geographic access challenges, particularly outside major centers. Brazil is focused on expanding specialist capacity and improving consistent access across its heterogeneous healthcare system. Canada’s publicly oriented system supports evidence-based care but faces regional differences in wait times and specialist availability. China is strengthening specialized services, laboratory capability, and clinical standardization across a highly diverse population. France and Germany maintain established allergy and immunology infrastructures, with attention to guideline implementation, reimbursement, and efficient referral. India has substantial unmet need alongside expanding private, public, and digital care models. Italy and Spain continue to emphasize coordinated specialist services and prevention within varied regional health systems. Japan has advanced diagnostics and clinical expertise, while demographic change and care coordination remain important considerations. Mexico is working to improve specialist access and diagnostic consistency across public and private settings. Russia’s allergy services reflect regional variation in infrastructure and access. South Korea combines sophisticated medical technology with strong urban healthcare capacity. The United Kingdom is emphasizing standardized pathways, primary-care coordination, and responsible use of specialist resources. The United States offers broad access to advanced therapies and diagnostics, but affordability, insurance coverage, and care fragmentation remain central issues.

Priorities for Leaders: Build Trustworthy, Accessible, and Integrated Allergy Care

Industry leaders should align diagnostic innovation with clinically validated use cases and clear interpretation guidance, avoiding overdiagnosis from isolated sensitization results. Investment should prioritize interoperable data systems, clinician training, patient education, adherence support, and referral pathways that connect primary care with specialists. Treatment portfolios should address both immediate symptom control and long-term disease modification, with safety monitoring and shared decision-making built into delivery models. Organizations should also design solutions for different resource settings, support responsible AI governance, strengthen supply resilience, and measure outcomes such as diagnostic accuracy, quality of life, treatment persistence, and avoidable healthcare utilization rather than relying only on product adoption.

Research Methodology: Evidence-Based Synthesis of Allergy Care Dynamics

This executive summary uses the defined allergy diagnostic and treatment scope and organizes findings across technologies, clinical pathways, care delivery, regulation, access, and patient needs. The assessment should be grounded in peer-reviewed research, clinical guidelines, regulatory publications, public-health sources, health-system documentation, and validated epidemiological evidence. Regional, group, and country comparisons are qualitative and consider healthcare infrastructure, specialist availability, reimbursement, diagnostic practice, treatment access, digital maturity, and policy context. No market estimates, market shares, forecasts, or company-specific claims are used. Interpretation should distinguish established evidence from emerging applications, particularly for AI-enabled tools and novel diagnostic workflows.

Conclusion: Better Outcomes Depend on Earlier, More Precise, and More Equitable Care

Allergy care is moving toward integrated pathways that combine accurate clinical assessment, fit-for-purpose diagnostics, personalized treatment, and sustained patient support. Advances in molecular testing, immunotherapy, biologics, digital services, and AI can improve decision-making, but their benefits depend on validation, affordability, professional oversight, and equitable implementation. Leaders who connect innovation with practical care delivery, workforce capability, data responsibility, and measurable patient outcomes will be best positioned to address the varied needs of allergy patients across regions and health systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Allergy Diagnostic & Treatment Market, by Treatment Type
7.1. Introduction
7.2. Immunotherapy
7.2.1. Subcutaneous Immunotherapy
7.2.2. Sublingual Immunotherapy
7.3. Pharmacotherapy
7.3.1. Antihistamines
7.3.2. Corticosteroids
7.3.3. Decongestants
7.3.4. Leukotriene Receptor Antagonists
8. Allergy Diagnostic & Treatment Market, by Diagnostics Type
8.1. Introduction
8.2. In Vitro
8.3. In Vivo
9. Allergy Diagnostic & Treatment Market, by Product Type
9.1. Introduction
9.2. Devices
9.2.1. Autoinjectors
9.2.2. Nebulizers
9.2.3. Skin Test Devices
9.3. Kits
9.3.1. Chemiluminescence Immunoassay Kits
9.3.2. Enzyme Linked Immunosorbent Assay Kits
9.3.3. Rapid Test Kits
9.4. Reagents
9.4.1. Enzymes
9.4.2. Monoclonal Antibodies
10. Allergy Diagnostic & Treatment Market, by Allergy Type
10.1. Introduction
10.2. Drug
10.2.1. NSAIDs
10.2.2. Penicillin
10.3. Environmental
10.3.1. Animal Dander
10.3.2. Dust Mite
10.3.3. Mold
10.3.4. Pollen
10.4. Food
10.4.1. Dairy
10.4.2. Peanuts
10.4.3. Shellfish
11. Allergy Diagnostic & Treatment Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Allergy Diagnostic & Treatment Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Allergy Diagnostic & Treatment Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 3M Health Care
15.2. Abbott Laboratories
15.3. Aerocrine AB
15.4. Aimmune Therapeutics, Inc.
15.5. ALK-Abelló A/S
15.6. Allergy Therapeutics PLC
15.7. Allergy, Inc.
15.8. Astana Pharma Ltd.
15.9. AstraZeneca PLC
15.10. Becton, Dickinson and Company
15.11. Bio-Rad Laboratories, Inc.
15.12. bioMérieux SA
15.13. Danaher Corporation
15.14. Eurofins Scientific SE
15.15. F. Hoffmann-La Roche AG
15.16. GlaxoSmithKline PLC
15.17. Halyard Health, Inc.
15.18. Hitachi Chemical Co., Ltd.
15.19. Hycor Biomedical, Inc.
15.20. Immunetics, Inc.
15.21. INO Therapeutics Ltd.
15.22. Lincoln Diagnostics, Inc.
15.23. Lofarma S.p.A.
15.24. Novartis International AG
15.25. Omega Diagnostics Group PLC
15.26. Siemens Healthineers AG
15.27. Stallergenes Greer, Inc.
15.28. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Allergy Diagnostic & Treatment Market, Years Considered for the Study
FIGURE 2. Global Allergy Diagnostic & Treatment Market, Research Design
FIGURE 3. Global Allergy Diagnostic & Treatment Market, Research Framework
FIGURE 4. Global Allergy Diagnostic & Treatment Market, Data Triangulation
FIGURE 5. Global Allergy Diagnostic & Treatment Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2025 vs 2032 (%)
FIGURE 7. Global Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2025 vs 2032 (%)
FIGURE 9. Global Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Allergy Diagnostic & Treatment Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 11. Global Allergy Diagnostic & Treatment Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2025 vs 2032 (%)
FIGURE 13. Global Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Allergy Diagnostic & Treatment Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Allergy Diagnostic & Treatment Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Allergy Diagnostic & Treatment Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Allergy Diagnostic & Treatment Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Allergy Diagnostic & Treatment Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Allergy Diagnostic & Treatment Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Allergy Diagnostic & Treatment Market Segmentation & Coverage
TABLE 2. Global Allergy Diagnostic & Treatment Market Size, 2017-2032 (USD Million)
TABLE 3. Global Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 4. Global Immunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Immunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Immunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Subcutaneous Immunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Subcutaneous Immunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Subcutaneous Immunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sublingual Immunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Sublingual Immunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Sublingual Immunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pharmacotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pharmacotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pharmacotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Decongestants Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Decongestants Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Decongestants Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Leukotriene Receptor Antagonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Leukotriene Receptor Antagonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Leukotriene Receptor Antagonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 29. Global In Vitro Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global In Vitro Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global In Vitro Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global In Vivo Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global In Vivo Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global In Vivo Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 36. Global Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Autoinjectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Autoinjectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Autoinjectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Nebulizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Nebulizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Nebulizers Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Skin Test Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Skin Test Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Skin Test Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Chemiluminescence Immunoassay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Chemiluminescence Immunoassay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Chemiluminescence Immunoassay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Enzyme Linked Immunosorbent Assay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Enzyme Linked Immunosorbent Assay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Enzyme Linked Immunosorbent Assay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Rapid Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Rapid Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Rapid Test Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 70. Global Drug Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Drug Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Drug Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global NSAIDs Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Penicillin Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Penicillin Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Penicillin Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Environmental Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Environmental Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Environmental Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Animal Dander Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Animal Dander Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Animal Dander Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Dust Mite Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Dust Mite Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Dust Mite Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Mold Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Mold Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Mold Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pollen Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Pollen Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Pollen Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Food Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Food Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Food Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Dairy Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Dairy Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Dairy Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Peanuts Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Peanuts Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Peanuts Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Shellfish Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Shellfish Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Shellfish Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Allergy Diagnostic & Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 120. North America Allergy Diagnostic & Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. North America Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 122. North America Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 123. North America Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 124. North America Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 125. North America Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. North America Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 127. North America Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 128. North America Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 129. North America Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 130. North America Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 131. North America Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 132. North America Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 133. Latin America Allergy Diagnostic & Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Latin America Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 135. Latin America Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 136. Latin America Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 137. Latin America Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 138. Latin America Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. Latin America Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 140. Latin America Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 141. Latin America Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 142. Latin America Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 143. Latin America Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 144. Latin America Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 145. Latin America Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 146. Europe Allergy Diagnostic & Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Europe Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 148. Europe Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 149. Europe Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 150. Europe Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 151. Europe Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. Europe Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 153. Europe Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 154. Europe Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 155. Europe Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 156. Europe Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 157. Europe Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 158. Europe Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 159. Middle East Allergy Diagnostic & Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Middle East Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 161. Middle East Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 162. Middle East Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 163. Middle East Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 164. Middle East Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. Middle East Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 166. Middle East Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 167. Middle East Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 168. Middle East Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 169. Middle East Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 170. Middle East Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 171. Middle East Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 172. Africa Allergy Diagnostic & Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Africa Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 174. Africa Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 175. Africa Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 176. Africa Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 177. Africa Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. Africa Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 179. Africa Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 180. Africa Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 181. Africa Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 182. Africa Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 183. Africa Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 184. Africa Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 185. Global Allergy Diagnostic & Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. ASEAN Allergy Diagnostic & Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. ASEAN Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 188. ASEAN Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 189. ASEAN Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 190. ASEAN Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 191. ASEAN Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. ASEAN Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 193. ASEAN Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 194. ASEAN Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 195. ASEAN Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 196. ASEAN Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 197. ASEAN Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 198. ASEAN Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 199. GCC Allergy Diagnostic & Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. GCC Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 201. GCC Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 202. GCC Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 203. GCC Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 204. GCC Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. GCC Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 206. GCC Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 207. GCC Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 208. GCC Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 209. GCC Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 210. GCC Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 211. GCC Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 212. European Union Allergy Diagnostic & Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. European Union Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 214. European Union Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 215. European Union Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 216. European Union Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 217. European Union Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. European Union Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 219. European Union Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 220. European Union Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 221. European Union Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 222. European Union Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 223. European Union Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 224. European Union Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 225. BRICS Allergy Diagnostic & Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. BRICS Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 227. BRICS Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 228. BRICS Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 229. BRICS Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 230. BRICS Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. BRICS Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 232. BRICS Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 233. BRICS Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 234. BRICS Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 235. BRICS Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 236. BRICS Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 237. BRICS Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 238. G7 Allergy Diagnostic & Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. G7 Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 240. G7 Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 241. G7 Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 242. G7 Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 243. G7 Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. G7 Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 245. G7 Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 246. G7 Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 247. G7 Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 248. G7 Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 249. G7 Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 250. G7 Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 251. NATO Allergy Diagnostic & Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 252. NATO Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 253. NATO Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 254. NATO Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 255. NATO Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 256. NATO Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. NATO Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 258. NATO Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 259. NATO Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 260. NATO Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 261. NATO Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 262. NATO Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 263. NATO Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 264. Global Allergy Diagnostic & Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 265. United States Allergy Diagnostic & Treatment Market Size, 2017-2032 (USD Million)
TABLE 266. United States Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 267. United States Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 268. United States Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 269. United States Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 270. United States Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. United States Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 272. United States Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 273. United States Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 274. United States Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 275. United States Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 276. United States Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 277. United States Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 278. Canada Allergy Diagnostic & Treatment Market Size, 2017-2032 (USD Million)
TABLE 279. Canada Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 280. Canada Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 281. Canada Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 282. Canada Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 283. Canada Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 284. Canada Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 285. Canada Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 286. Canada Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 287. Canada Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 288. Canada Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 289. Canada Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 290. Canada Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 291. Mexico Allergy Diagnostic & Treatment Market Size, 2017-2032 (USD Million)
TABLE 292. Mexico Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 293. Mexico Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 294. Mexico Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 295. Mexico Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 296. Mexico Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. Mexico Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 298. Mexico Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 299. Mexico Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 300. Mexico Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 301. Mexico Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 302. Mexico Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 303. Mexico Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 304. Brazil Allergy Diagnostic & Treatment Market Size, 2017-2032 (USD Million)
TABLE 305. Brazil Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 306. Brazil Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 307. Brazil Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 308. Brazil Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 309. Brazil Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. Brazil Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 311. Brazil Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 312. Brazil Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 313. Brazil Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 314. Brazil Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 315. Brazil Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 316. Brazil Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 317. United Kingdom Allergy Diagnostic & Treatment Market Size, 2017-2032 (USD Million)
TABLE 318. United Kingdom Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 319. United Kingdom Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 320. United Kingdom Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 321. United Kingdom Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 322. United Kingdom Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 323. United Kingdom Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 324. United Kingdom Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 325. United Kingdom Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 326. United Kingdom Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 327. United Kingdom Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 328. United Kingdom Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 329. United Kingdom Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 330. Germany Allergy Diagnostic & Treatment Market Size, 2017-2032 (USD Million)
TABLE 331. Germany Allergy Diagnostic & Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 332. Germany Allergy Diagnostic & Treatment Market Size, by Immunotherapy, 2017-2032 (USD Million)
TABLE 333. Germany Allergy Diagnostic & Treatment Market Size, by Pharmacotherapy, 2017-2032 (USD Million)
TABLE 334. Germany Allergy Diagnostic & Treatment Market Size, by Diagnostics Type, 2017-2032 (USD Million)
TABLE 335. Germany Allergy Diagnostic & Treatment Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 336. Germany Allergy Diagnostic & Treatment Market Size, by Devices, 2017-2032 (USD Million)
TABLE 337. Germany Allergy Diagnostic & Treatment Market Size, by Kits, 2017-2032 (USD Million)
TABLE 338. Germany Allergy Diagnostic & Treatment Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 339. Germany Allergy Diagnostic & Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 340. Germany Allergy Diagnostic & Treatment Market Size, by Drug, 2017-2032 (USD Million)
TABLE 341. Germany Allergy Diagnostic & Treatment Market Size, by Environmental, 2017-2032 (USD Million)
TABLE 342. Germany Allergy Diagnostic & Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 343. France Allergy Diagnostic & Treatment Mar

Companies Mentioned

  • 3M Health Care
  • Abbott Laboratories
  • Aerocrine AB
  • Aimmune Therapeutics, Inc.
  • ALK-Abelló A/S
  • Allergy Therapeutics PLC
  • Allergy, Inc.
  • Astana Pharma Ltd.
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Halyard Health, Inc.
  • Hitachi Chemical Co., Ltd.
  • Hycor Biomedical, Inc.
  • Immunetics, Inc.
  • INO Therapeutics Ltd.
  • Lincoln Diagnostics, Inc.
  • Lofarma S.p.A.
  • Novartis International AG
  • Omega Diagnostics Group PLC
  • Siemens Healthineers AG
  • Stallergenes Greer, Inc.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Allergy Diagnostics and Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Allergy Diagnostics and Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 186 Pages
  • Global
From
Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2026-2034 - Product Image

Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2026-2034

  • Report
  • 145 Pages
  • Global
From
Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2026-2032 - Product Image

Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Allergy Diagnostics Therapeutics Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Allergy Diagnostics Therapeutics Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 81 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.